Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats

Nephrology Dialysis Transplantation

Volumn 21, Issue 5, 2006, Pages 1198-1204

  Weissgarten, Joshua ^a   Berman, Sylvia ^a   Efrati, Shai ^a   Rapoport, Micha ^a   Averbukh, Zhan ^a   Feldman, Leonid ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiotensin II; Apoptosis; Diabetes; PPAR; Pregnancy; Proliferation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; MESANGIUM CELL; NICK END LABELING; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR MESANGIUM; IN SITU NICK-END LABELING; PPAR GAMMA; PREGNANCY; PREGNANCY, ANIMAL; PROBABILITY; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; STREPTOZOCIN; THIAZOLIDINEDIONES; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646198038     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk084     Document Type: Article

References (20)

1. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20: 649-688
2. Hsueh W, Nicholas S. Peroxisome proliferator-activated receptor-gamma in the renal mesangium. Curr Opin Nephrol Hypertens 2002; 11: 191-195
3. Baylis C, Atzpodien E, Freshour G, Engels K. Peroxisome proliferator-activating receptor γ agonists provide superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther 2003; 307: 854-860
4. Nicholas S, Kawano Y, Wakino S, Collins A, Hsueh W. Expression and function of peroxisome proliferator-activated receptor gamma in mesangial cells. Hypertension 2001; 37: 722-727
5. Chinetti G, Griglio S, Antonucci M et al. Activation of peroxisome proliferators activated receptors alpha and gamma induces apoptosis of human monocyte derived macrophages. J Biol Chem 1998; 273: 25573-25580
6. Schaiff W, Carlson M, Smith S, Levy R, Nelson D, Sadovsky Y. Peroxisome proliferator-activated receptorgamma modulates differentiation of human trophoblasts in a ligand-specific manner. J Clin Endocrinol Metab 2000; 85: 3874-3881
7. Waite L, Person E, Zhou Y, Lim K, Skcanlan T, Taylor R. Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab 2000; 85: 3808-3814
8. Peer A, Averbukh Z, Berman S, Modai D, Averbukh M, Weissgarten J. Contrast media augmented apoptosis of cultured renal mesangial, tubular epithelial, endothelial and hepatic cells. Invest Radiol 2003; 38: 177-182
9. Goto M, Mukoyama M, Suga S et al. Growth dependent induction of angiotensin II type 2 receptor in rat mesangial cells. Hypertension 1997; 30: 358-362
10. Walker A, Chattington P, Buckingham R, Williams G. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes 1999; 48: 1448-1453
11. Buchanan T, Meehan W, Jeng Y et al. Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J Clin Invest 1995; 96: 354-360
12. Diep Q, Mabrouk M, Cohn J et al. Structure, endothelial function, cell growth and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-γ. Circulation 2002; 105: 2296-2305
13. Rovin B, Lu L, Cosio A. Cyclopentenone prostaglandins inhibit cytokine induced NF-kB activation and chemokine production by human mesangial cells. J Am Soc Nephrol 2001; 12: 1659-1667
14. Barnes P. Nuclear factor-kappa B. Int J Biochem Cell Biol 1997; 29: 867-870
15. Verma I, Stevenson J, Schwarze E, van Antwerp D, Miyamoto S. Rel/ NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev 1995; 9: 2723-2735
16. Burgess H, Daugherty L, Thacher T et al. PPAR-gamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005; 288: 1146-1153
17. Asano T, Tatsuma N, Yoshida J et al. Association of angiotensin converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy. Clin Nephrol 1999; 51: 335-340
18. Kurogi Y. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 2003; 23: 15-31
19. Nahle Z, Polakoff J, Davuluri R et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 2002; 4: 859-864
20. Lorenzo O, Ruis-Ortega M, Suzuki Y et al. Angiotensin III activates nuclear transcription factor-kB in cultured mesangial cells mainly via AT(2) receptors: Studies with AT(1) receptor knockout mice. J Am Soc Nephrol 2002; 13: 1162-1171